X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (48) 48
female (36) 36
index medicus (35) 35
male (35) 35
middle aged (34) 34
adult (30) 30
aged (30) 30
cancer (30) 30
chemotherapy (30) 30
oncology (30) 30
hematology (22) 22
lymphomas (22) 22
adolescent (18) 18
care and treatment (15) 15
therapy (15) 15
lymphoma (14) 14
young adult (14) 14
antineoplastic combined chemotherapy protocols - therapeutic use (13) 13
patients (13) 13
radiotherapy (13) 13
rituximab (13) 13
disease (12) 12
antineoplastic combined chemotherapy protocols - administration & dosage (10) 10
clinical trials (10) 10
doxorubicin - administration & dosage (10) 10
hodgkin disease - drug therapy (10) 10
prospective studies (10) 10
vincristine - administration & dosage (10) 10
antineoplastic combined chemotherapy protocols - adverse effects (9) 9
cyclophosphamide (9) 9
doxorubicin (9) 9
epidemiology (9) 9
hodgkin's disease (9) 9
risk factors (9) 9
treatment outcome (9) 9
aged, 80 and over (8) 8
cyclophosphamide - administration & dosage (8) 8
elderly-patients (8) 8
hodgkin disease - radiotherapy (8) 8
hodgkin lymphoma (8) 8
prednisone - administration & dosage (8) 8
b-cell lymphoma (7) 7
follow-up studies (7) 7
hematology, oncology and palliative medicine (7) 7
leukemia (7) 7
life sciences (7) 7
mortality (7) 7
neutropenia (7) 7
radiation therapy (7) 7
research (7) 7
risk (7) 7
survival (7) 7
age (6) 6
bleomycin - administration & dosage (6) 6
combined modality therapy (6) 6
cyclophosphamide - adverse effects (6) 6
disease-free survival (6) 6
doxorubicin - adverse effects (6) 6
hodgkin disease - mortality (6) 6
infectious diseases (6) 6
medicine & public health (6) 6
medicine, general & internal (6) 6
microbiology (6) 6
neoplasm staging (6) 6
non-hodgkin lymphoma (6) 6
non-hodgkins-lymphoma (6) 6
procarbazine - administration & dosage (6) 6
studies (6) 6
survivors (6) 6
vinblastine - administration & dosage (6) 6
vincristine (6) 6
vincristine - adverse effects (6) 6
[ sdv.can ] life sciences [q-bio]/cancer (5) 5
abridged index medicus (5) 5
age factors (5) 5
analysis (5) 5
antibodies, monoclonal, murine-derived - administration & dosage (5) 5
antibodies, monoclonal, murine-derived - adverse effects (5) 5
antifungal agents - administration & dosage (5) 5
antimitotic agents (5) 5
antineoplastic agents (5) 5
cancer therapies (5) 5
childhood-cancer (5) 5
diagnosis (5) 5
lymphoma, large b-cell, diffuse - drug therapy (5) 5
lymphoma, non-hodgkin - drug therapy (5) 5
medical prognosis (5) 5
netherlands - epidemiology (5) 5
prednisone (5) 5
prednisone - adverse effects (5) 5
procarbazine (5) 5
prognosis (5) 5
prophylaxis (5) 5
radiology, nuclear medicine & medical imaging (5) 5
remission induction (5) 5
survival analysis (5) 5
survival rate (5) 5
vinblastine (5) 5
aspergillosis (4) 4
breast-cancer (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nederlands tijdschrift voor geneeskunde, ISSN 0028-2162, 01/2019, Volume 163
Since 2017, the non-invasive prenatal test (NIPT) has been offered to all pregnant woman in the Netherlands in the context of the TRIDENT-2 study, which has... 
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 8, pp. 1081 - 1093
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 5/2008, Volume 46, Issue 9, pp. 1401 - 1408
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 2015, Volume 373, Issue 26, pp. 2499 - 2511
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2010, Volume 5, Issue 5, p. e10840
textabstractBackground: Catheter-related bloodstream infection (CRBSI) results in significant attributable morbidity and mortality. In this randomized,... 
MICROORGANISMS | DIAGNOSIS | NEGATIVE STAPHYLOCOCCAL BACTEREMIA | DOUBLE-BLIND TRIAL | MULTIDISCIPLINARY SCIENCES | INTRAVASCULAR DEVICES | POLYURETHANE | NEUTROPENIC PATIENTS | CRITICALLY-ILL PATIENTS | BLOOD-STREAM INFECTIONS | ATTRIBUTABLE MORTALITY | Catheter-Related Infections - etiology | Drug Administration Schedule | Humans | Middle Aged | Kaplan-Meier Estimate | Ethanol - administration & dosage | Male | Catheter-Related Infections - prevention & control | Young Adult | Bacteremia - prevention & control | Ethanol - adverse effects | Adolescent | Catheters, Indwelling - adverse effects | Aged, 80 and over | Bacteremia - etiology | Placebos | Adult | Female | Aged | Care and treatment | Catheterization | Mortality | Clinical trials | Alcohol | Bacteremia | Preventive health services | Prevention | Infection | Complications and side effects | Chemotherapy | Alcohol, Denatured | Analysis | Medicine, Preventive | Cancer | Intensive care | Systematic review | Epidemiology | Incidence | Confidence intervals | Hydrochloric acid | Microorganisms | Randomization | Reduction | Translocation | Mucositis | Statistical analysis | Ethanol | Hematology | Internal medicine | Medical instruments | Mechanical properties | Antimicrobial agents | Locks | Patients | Catheters | Morbidity | Medicine | Studies | Disease prevention | Hospitals | Infectious diseases | Biofilms | Antibiotics | Sepsis
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2014, Volume 32, Issue 12, pp. 1188 - 1194
Journal Article
PLoS ONE, ISSN 1932-6203, 2017, Volume 12, Issue 7, p. e0181313
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2007, Volume 357, Issue 19, pp. 1916 - 1927
Journal Article
FUTURE ONCOLOGY, ISSN 1479-6694, 04/2019, Volume 15, Issue 11, pp. 1197 - 1205
The decisive factor in selecting a treatment regimen for a frail patient with aggressive non-Hodgkin's lymphoma is identifying whether a patient is fit enough... 
NONPEGYLATED LIPOSOMAL DOXORUBICIN | treatment | RISK-FACTORS | INTERNATIONAL-SOCIETY | elderly | HEART-FAILURE | frail | COMPREHENSIVE GERIATRIC ASSESSMENT | CONVENTIONAL DOXORUBICIN | cardiac comorbidities | OLDER CANCER-PATIENTS | CO-MORBIDITY | B-CELL LYMPHOMA | ONCOLOGY | non-Hodgkin's lymphoma | ELDERLY-PATIENTS
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 12/2018, Volume 59, Issue 12, p. 1831
We aimed to assess the interobserver agreement of interim PET (I-PET) and end-of-treatment PET (EoT-PET) using the Deauville score (DS) in first-line diffuse... 
Randomization | Lymphocytes B | Positron emission | Clinical trials | Rituximab | Tomography | Lymphomas | Lymphoma | Patients | Positron emission tomography | B-cell lymphoma
Journal Article